FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck | Gardasil

Merck's Gardasil taken up by 37% of teen girls

Tools

A CDC study shows that, nationwide, 37 percent of teen girls received the human papilloma virus vaccine Gardasil, a mainline defense against cervical cancer. Based on a 2008 telephone survey, researchers found that three New England states boasted the highest vaccine rates--more than 50 percent--while Mississippi, Georgia and South Carolina mustered less than 20 percent. Article


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Gardasil   Merck